| Product Code: ETC9625271 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Neuroblastoma Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Neuroblastoma Market - Industry Life Cycle |
3.4 Taiwan Neuroblastoma Market - Porter's Five Forces |
3.5 Taiwan Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Taiwan Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Taiwan Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Taiwan Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neuroblastoma diagnosis and treatment in Taiwan |
4.2.2 Technological advancements in neuroblastoma treatment options |
4.2.3 Growing healthcare infrastructure and facilities in Taiwan |
4.3 Market Restraints |
4.3.1 High treatment costs associated with neuroblastoma |
4.3.2 Limited availability of specialized healthcare professionals and facilities for neuroblastoma treatment in Taiwan |
5 Taiwan Neuroblastoma Market Trends |
6 Taiwan Neuroblastoma Market, By Types |
6.1 Taiwan Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Taiwan Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Taiwan Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Taiwan Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Taiwan Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Taiwan Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Taiwan Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Taiwan Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Taiwan Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Taiwan Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Taiwan Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Taiwan Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Taiwan Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Taiwan Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Taiwan Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Neuroblastoma Market Import-Export Trade Statistics |
7.1 Taiwan Neuroblastoma Market Export to Major Countries |
7.2 Taiwan Neuroblastoma Market Imports from Major Countries |
8 Taiwan Neuroblastoma Market Key Performance Indicators |
8.1 Survival rates of neuroblastoma patients in Taiwan |
8.2 Number of clinical trials for neuroblastoma conducted in Taiwan |
8.3 Adoption rate of innovative neuroblastoma treatment technologies in Taiwan |
9 Taiwan Neuroblastoma Market - Opportunity Assessment |
9.1 Taiwan Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Taiwan Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Taiwan Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Taiwan Neuroblastoma Market - Competitive Landscape |
10.1 Taiwan Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here